<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8622948" created="16/05/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8622948</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="Rel-deficient_T_cell" sem="Cell_natural"><term id="A31" sem="Protein_molecule">Rel</term>-deficient T cells</term> exhibit defects in production of <term id="T2" lex="interleukin_3" sem="Protein_molecule">interleukin 3</term> and <term id="T3" lex="granulocyte-macrophage_colony-stimulating_factor" sem="Protein_molecule">granulocyte-macrophage colony-stimulating factor</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Rel-deficient T cells exhibit defects in <clueType>production</clueType> <linkTheme>of</linkTheme> interleukin 3 and granulocyte-macrophage colony-stimulating factor.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T3"/>
<clue>Rel-deficient T cells exhibit defects in <clueType>production</clueType> <linkTheme>of</linkTheme> interleukin 3 and granulocyte-macrophage colony-stimulating factor.</clue>
</event>
<event KT="Analysis" id="E3">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<clue><clueLoc>Rel-deficient T cells</clueLoc> <clueKT>exhibit</clueKT> <clueType>defects</clueType> <linkTheme>in</linkTheme> production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.</clue>
</event>
<event KT="Analysis" id="E4">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<clue><clueLoc>Rel-deficient T cells</clueLoc> <clueKT>exhibit</clueKT> <clueType>defects</clueType> <linkTheme>in</linkTheme> production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.</clue>
</event>
<event KT="Other" id="E71">
<type class="Negative_regulation"/>
<theme idref="A31"/>
<clue>Rel-<clueType>deficient</clueType> <clueLoc>T cells</clueLoc> exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T4" lex="c-rel_protooncogene" sem="DNA_domain_or_region">c-rel protooncogene</term> encodes a subunit of the <term id="T5" lex="NF-kappa_B-like_family_of_transcription_factor" sem="Protein_family_or_group"><term id="T6" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>-like family of <term id="T7" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term></term>.</sentence>
<sentence id="S3">Mice lacking <term id="T8" lex="Rel" sem="Protein_family_or_group">Rel</term> are defective in <term id="A20" sem="Protein_family_or_group">mitogenic</term> activation of <term id="A1" sem="Cell_natural">B</term> and <term id="A2" sem="Cell_natural">T</term> <term id="A3" sem="Cell_natural">lymphocytes</term> and display impaired <term id="T10" lex="humoral_immunity" sem="Other">humoral immunity</term>.</sentence>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="A1" idref1="A3"/>
<cause idref="A20"/>
<clue>Mice lacking Rel are defective in mitogenic <clueType>activation</clueType> <linkTheme>of</linkTheme> B and T lymphocytes and display impaired humoral immunity.</clue>
<comment>NER: T9 DEL</comment></event>
<event KT="Other" id="E6">
<type class="Physiological_process"/>
<theme idref="A2" idref1="A3"/>
<cause idref="A20"/>
<clue>Mice lacking Rel are defective in mitogenic <clueType>activation</clueType> <linkTheme>of</linkTheme> B and T lymphocytes and display impaired humoral immunity.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<clue><clueLoc>Mice lacking Rel</clueLoc> are <clueType>defective</clueType> <linkTheme>in</linkTheme> mitogenic activation of B and T lymphocytes and display impaired humoral immunity.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<clue><clueLoc>Mice lacking Rel</clueLoc> are <clueType>defective</clueType> <linkTheme>in</linkTheme> mitogenic activation of B and T lymphocytes and display impaired humoral immunity.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Negative_regulation"/>
<theme idref="T10"/>
<clue><clueLoc>Mice lacking Rel</clueLoc> are defective in mitogenic activation of B and T lymphocytes and <clueKT>display</clueKT> <clueType>impaired</clueType> humoral immunity.</clue>
</event>
<event KT="Other" id="E72">
<type class="Negative_regulation"/>
<theme idref="T8"/>
<clue><clueLoc>Mice</clueLoc> <clueType>lacking</clueType> Rel are defective in mitogenic activation of B and T lymphocytes and display impaired humoral immunity.</clue>
</event>
<sentence id="S4">In an attempt to identify changes in <term id="T11" lex="gene_expression" sem="Other">gene expression</term> that accompany the <term id="T12" lex="T-cell_stimulation_defect" sem="Other"><term id="A32" sem="Cell_natural">T-cell</term> stimulation defects</term> associated with the loss of <term id="T13" lex="Rel" sem="Protein_family_or_group">Rel</term>, we have examined the expression of <term id="T14" lex="cell_surface_activation_marker" sem="Protein_family_or_group">cell surface activation markers</term> and <term id="A4" sem="Protein_family_or_group">cytokine</term> production in mitogen-stimulated <term id="T15" lex="Rel-/-_T_cell" sem="Cell_natural"><term id="T16" lex="Rel" sem="Protein_family_or_group">Rel</term>-/- T cells</term>.</sentence>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>In an attempt to identify changes in gene expression that accompany the T-cell stimulation defects associated with the loss of Rel, we have <clueKT>examined</clueKT> the <clueType>expression</clueType> <linkTheme>of</linkTheme> cell surface activation markers and cytokine production <clueLoc>in mitogen-stimulated Rel-/- T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E11" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>In an attempt to identify changes in gene expression that accompany the T-cell stimulation defects associated with the loss of Rel, we have examined the expression of cell surface activation markers and cytokine <clueType>production</clueType> <clueLoc>in mitogen-stimulated Rel-/- T cells.</clueLoc></clue>
</event>
<event KT="Other" id="E12">
<type class="Negative_regulation"/>
<theme idref="T13"/>
<clue>In an attempt to identify changes in gene expression that accompany the T-cell stimulation defects associated with the <clueType>loss</clueType> <linkTheme>of</linkTheme> Rel, we have examined the expression of cell surface activation markers and cytokine production in mitogen-stimulated Rel-/- T cells.</clue>
</event>
<event KT="Other" id="E74">
<type class="Physiological_process"/>
<theme idref="A32"/>
<clue>In an attempt to identify changes in gene expression that accompany the T-cell <clueType>stimulation</clueType> defects associated with the loss of Rel, we have examined the expression of cell surface activation markers and cytokine production in mitogen-stimulated Rel-/- T cells.</clue>
</event>
<event KT="Other" id="E75">
<type class="Negative_regulation"/>
<theme idref="E74"/>
<clue>In an attempt to identify changes in gene expression that accompany the T-cell stimulation <clueType>defects</clueType> associated with the loss of Rel, we have examined the expression of cell surface activation markers and cytokine production in mitogen-stimulated Rel-/- T cells.</clue>
</event>
<event KT="Investigation" id="E76">
<type class="Regulation"/>
<theme idref="T11"/>
<clue>In an attempt <clueKT>to identify</clueKT> <clueType>changes</clueType> <linkTheme>in</linkTheme> gene expression that accompany the T-cell stimulation defects associated with the loss of Rel, we have examined the expression of cell surface activation markers and cytokine production in mitogen-stimulated Rel-/- T cells.</clue>
</event>
<event KT="Other" id="E77">
<type class="Positive_regulation"/>
<theme idref="E76"/>
<cause idref="E75"/>
<clue>In an attempt to identify changes in gene expression that <clueType>accompany</clueType> the T-cell stimulation defects associated with the loss of Rel, we have examined the expression of cell surface activation markers and cytokine production in mitogen-stimulated Rel-/- T cells.</clue>
</event>
<event KT="Analysis" id="E13" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E76"/>
<theme idref="E12"/>
<clue>In an attempt to identify changes in gene expression that accompany the T-cell stimulation defects <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> the loss of Rel, we have examined the expression of cell surface activation markers and cytokine production in mitogen-stimulated Rel-/- T cells.</clue>
</event>
<sentence id="S5">The expression of <term id="A5" sem="Protein_family_or_group">cell surface markers</term> including the <term id="T17" lex="interleukin_2_receptor_alpha_(IL-2R_alpha)_chain" sem="Protein_molecule">interleukin 2 receptor alpha (<term id="T18" lex="IL-2R_alpha" sem="Protein_molecule">IL-2R alpha</term>) chain</term> (<term id="T19" lex="CD25" sem="Protein_molecule">CD25</term>), <term id="T20" lex="CD69" sem="Protein_molecule">CD69</term> and <term id="T21" lex="L-selectin" sem="Protein_molecule">L-selectin</term> (<term id="T22" lex="CD62" sem="Protein_molecule">CD62</term>) is normal in <term id="T23" lex="mitogen-activated_Rel-/-_T_cell" sem="Cell_cultured"><term id="A33" sem="Protein_family_or_group">mitogen</term>-activated <term id="A34" sem="Cell_natural"><term id="T24" lex="Rel" sem="Protein_family_or_group">Rel</term>-/- T cells</term></term>, but <term id="T25" lex="cytokine_production" sem="Other"><term id="T26" lex="cytokine" sem="Protein_family_or_group">cytokine</term> production</term> is impaired.</sentence>
<event id="E14">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> cell surface markers including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal <clueLoc>in mitogen-activated Rel-/- T cells</clueLoc>, but cytokine production is impaired.</clue>
</event>
<event id="E16">
<type class="Gene_expression"/>
<theme idref="T19"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>cell surface markers</corefTheme> including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal <clueLoc>in mitogen-activated Rel-/- T cells</clueLoc>, but cytokine production is impaired.</clue>
</event>
<event id="E17">
<type class="Gene_expression"/>
<theme idref="T20"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>cell surface markers</corefTheme> including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal <clueLoc>in mitogen-activated Rel-/- T cells</clueLoc>, but cytokine production is impaired.</clue>
</event>
<event id="E18">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>cell surface markers</corefTheme> including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal <clueLoc>in mitogen-activated Rel-/- T cells</clueLoc>, but cytokine production is impaired.</clue>
</event>
<event id="E19">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>The expression of cell surface markers including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal in mitogen-activated Rel-/- T cells, but cytokine <clueType>production</clueType> is impaired.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<clue>The expression of cell surface markers including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal <clueLoc>in mitogen-activated Rel-/- T cells</clueLoc>, but cytokine production is <clueType>impaired</clueType>.</clue>
</event>
<event id="E21">
<type class="Physiological_process"/>
<theme idref="A34"/>
<cause idref="A33"/>
<clue>The expression of cell surface markers including the interleukin 2 receptor alpha (IL-2R alpha) chain (CD25), CD69 and L-selectin (CD62) is normal in mitogen-<clueType>activated</clueType> Rel-/- T cells, but cytokine production is impaired.</clue>
</event>
<sentence id="S6">In <term id="T27" lex="Rel-/-_splenic_T_cell_culture" sem="Cell_cultured"><term id="T28" lex="Rel" sem="Protein_family_or_group">Rel</term>-/- splenic T cell cultures</term> stimulated with <term id="T29" lex="phorbol_12-myristate_13-acetate" sem="Organic_compound_other">phorbol 12-myristate 13-acetate</term> and <term id="T30" lex="ionomycin" sem="Organic_compound_other">ionomycin</term>, the levels of <term id="A6" sem="Protein_molecule">IL-3</term>, <term id="A7" sem="Protein_molecule">IL-5</term>, <term id="T31" lex="granulocyte-_macrophage_colony-stimulating_factor" sem="Protein_molecule">granulocyte- macrophage colony-stimulating factor</term> (<term id="T32" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term>), <term id="T33" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term> (<term id="T34" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>), and <term id="T35" lex="gamma_interferon" sem="Protein_molecule">gamma interferon</term> (<term id="T36" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>) were only 2- to 3-fold lower compared with normal T cells.</sentence>
<event id="E26">
<type class="Physiological_process"/>
<theme idref="T27"/>
<cause idref="T29"/>
<clue>In Rel-/- splenic T cell cultures <clueType>stimulated</clueType> <linkTheme>with</linkTheme> phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold lower compared with normal T cells.</clue>
</event>
<event id="E27">
<type class="Physiological_process"/>
<theme idref="T27"/>
<cause idref="T30"/>
<clue>In Rel-/- splenic T cell cultures <clueType>stimulated</clueType> <linkTheme>with</linkTheme> phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold lower compared with normal T cells.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="A6"/>
<cause idref="E26"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="A7"/>
<cause idref="E26"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="T32"/>
<cause idref="E26"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="E26"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="E26"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="A6"/>
<cause idref="E27"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="A7"/>
<cause idref="E27"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="T32"/>
<cause idref="E27"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="E27"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<event id="E37">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="E27"/>
<clue>In Rel-/- splenic T cell cultures stimulated with phorbol 12-myristate 13-acetate and ionomycin, the levels of IL-3, IL-5, granulocyte- macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were only 2- to 3-fold <clueType>lower</clueType> compared with normal T cells.</clue>
</event>
<sentence id="S7">In contrast, <term id="T37" lex="anti-CD3" sem="Protein_family_or_group">anti-CD3</term> and <term id="T38" lex="anti-CD28" sem="Protein_family_or_group">anti-CD28</term> stimulated <term id="T39" lex="Rel-/-_T_cell" sem="Cell_cultured"><term id="T40" lex="Rel" sem="Protein_family_or_group">Rel</term>-/- T cells</term>, which fail to proliferate, make little or no detectable <term id="T41" lex="cytokine" sem="Protein_family_or_group">cytokines</term>.</sentence>
<event id="E38">
<type class="Physiological_process"/>
<theme idref="T39"/>
<cause idref="T37"/>
<clue>In contrast, anti-CD3 and anti-CD28 <clueType>stimulated</clueType> Rel-/- T cells, which fail to proliferate, make little or no detectable cytokines.</clue>
</event>
<event id="E39">
<type class="Physiological_process"/>
<theme idref="T39"/>
<cause idref="T38"/>
<clue>In contrast, anti-CD3 and anti-CD28 <clueType>stimulated</clueType> Rel-/- T cells, which fail to proliferate, make little or no detectable cytokines.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E300">
<type class="Cellular_physiological_process"/>
<theme idref="T39"/>
<clue>In contrast, <clueLoc>anti-CD3</clueLoc> and anti-CD28 <clueLoc>stimulated Rel-/- T cells</clueLoc>, which <cluePolarity>fail</cluePolarity> to <clueType>proliferate</clueType>, make little or no detectable cytokines.</clue>
</event>
<event KT="Fact" Polarity="Negative" assertion="non-exist" id="E301">
<type class="Cellular_physiological_process"/>
<theme idref="T39"/>
<clue>In contrast, anti-CD3 and <clueLoc>anti-CD28 stimulated Rel-/- T cells</clueLoc>, which <cluePolarity>fail</cluePolarity> to <clueType>proliferate</clueType>, make little or no detectable cytokines.</clue>
</event>
<event Manner="Low" id="E302">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>In contrast, <clueLoc>anti-CD3</clueLoc> and anti-CD28 <clueLoc>stimulated Rel-/- T cells</clueLoc>, which fail to proliferate, make <clueManner>little or no</clueManner> <clueType><clueKT>detectable</clueKT></clueType> cytokines.</clue>
</event>
<event Manner="Low" id="E303">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>In contrast, anti-CD3 and <clueLoc>anti-CD28 stimulated Rel-/- T cells</clueLoc>, which fail to proliferate, make <clueManner>little or no</clueManner> <clueType><clueKT>detectable</clueKT></clueType> cytokines.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E304">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>In contrast, <clueLoc>anti-CD3</clueLoc> and anti-CD28 <clueLoc>stimulated Rel-/- T cells</clueLoc>, which fail to proliferate, make <clueManner>little or no</clueManner> <clueType><clueKT>detectable</clueKT></clueType> cytokines.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E305">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>In contrast, anti-CD3 and <clueLoc>anti-CD28 stimulated Rel-/- T cells</clueLoc>, which fail to proliferate, make <clueManner>little or no</clueManner> <clueType><clueKT>detectable</clueKT></clueType> cytokines.</clue>
</event>
<sentence id="S8">Exogenous <term id="T42" lex="IL-2" sem="Protein_molecule">IL-2</term>, which restitutes the proliferative response of the <term id="A22" sem="Cell_natural">anti-CD3-</term> and <term id="A23" sem="Cell_natural">anti-CD28-</term><term id="A24" sem="Cell_natural">treated <term id="A35" sem="Cell_natural">Rel-/- T cells</term></term>, restores production of <term id="A21" sem="Protein_molecule">IL-5</term>, <term id="T44" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>, and <term id="T45" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>, but not <term id="T46" lex="IL-3" sem="Protein_molecule">IL-3</term> and <term id="T47" lex="GM-CSF_expression" sem="Other"><term id="T48" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> expression</term> to approximately normal levels.</sentence>
<event id="E51">
<type class="Gene_expression"/>
<theme idref="A21"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores <clueType>production</clueType> <linkTheme>of</linkTheme> IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event id="E52">
<type class="Gene_expression"/>
<theme idref="T44"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores <clueType>production</clueType> <linkTheme>of</linkTheme> IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event id="E53">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores <clueType>production</clueType> <linkTheme>of</linkTheme> IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event id="E54">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF <clueType>expression</clueType> to approximately normal levels.</clue>
</event>
<event id="E55">
<type class="Gene_expression"/>
<theme idref="T48"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF <clueType>expression</clueType> to approximately normal levels.</clue>
</event>
<event KT="Other" id="E56">
<type class="Cellular_physiological_process"/>
<theme idref="A22" idref1="A24"/>
<clue>Exogenous IL-2, which restitutes the <clueType>proliferative response</clueType> <linkTheme>of</linkTheme> the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
<comment>NER T43 DEL</comment></event>
<event KT="Other" id="E57">
<type class="Cellular_physiological_process"/>
<theme idref="A23" idref1="A24"/>
<clue>Exogenous IL-2, which restitutes the <clueType>proliferative response</clueType> <linkTheme>of</linkTheme> the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event KT="Fact" id="E58">
<type class="Positive_regulation"/>
<theme idref="E56"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which <clueType>restitutes</clueType> the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event KT="Fact" id="E59">
<type class="Positive_regulation"/>
<theme idref="E57"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which <clueType>restitutes</clueType> the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event id="E60">
<type class="Positive_regulation"/>
<theme idref="E51"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, <clueType>restores</clueType> production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event id="E61">
<type class="Positive_regulation"/>
<theme idref="E52"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, <clueType>restores</clueType> production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event id="E62">
<type class="Positive_regulation"/>
<theme idref="E53"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, <clueType>restores</clueType> production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E63">
<type class="Positive_regulation"/>
<theme idref="E54"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, <clueType>restores</clueType> production of IL-5, TNF-alpha, and IFN-gamma, but <cluePolarity>not</cluePolarity> IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E64">
<type class="Positive_regulation"/>
<theme idref="E55"/>
<cause idref="T42"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, <clueType>restores</clueType> production of IL-5, TNF-alpha, and IFN-gamma, but <cluePolarity>not</cluePolarity> IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event KT="Method" id="E65">
<type class="Artificial_process"/>
<theme idref="A22"/>
<theme idref="A24"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-<clueType>treated</clueType> Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<event KT="Method" id="E66">
<type class="Artificial_process"/>
<theme idref="A23"/>
<theme idref="A24"/>
<clue>Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-<clueType>treated</clueType> Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.</clue>
</event>
<sentence id="S9">In contrast to <term id="T49" lex="mitogen-activated_Rel-/-_T_cell" sem="Cell_cultured"><term id="A36" sem="Protein_family_or_group">mitogen</term>-activated <term id="A37" sem="Cell_natural"><term id="T50" lex="Rel" sem="Protein_family_or_group">Rel</term>-/- T cells</term></term>, <term id="A38" sem="Lipid">lipopolysaccharide</term>-stimulated <term id="T51" lex="Rel-/-_macrophage" sem="Cell_cultured"><term id="T52" lex="Rel" sem="Protein_family_or_group">Rel</term>-/- macrophages</term> produce higher than normal levels of <term id="T53" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term>.</sentence>
<event id="E44">
<type class="Positive_regulation"/>
<theme idref="T53"/>
<clue>In contrast to mitogen-activated Rel-/- T cells, <clueLoc>lipopolysaccharide-stimulated Rel-/- macrophages</clueLoc> <clueType>produce higher</clueType> than normal levels of GM-CSF.</clue>
</event>
<event KT="Analysis" id="E81">
<type class="Physiological_process"/>
<theme idref="A37"/>
<cause idref="A36"/>
<clue><clueKT>In contrast to</clueKT> mitogen-<clueType>activated</clueType> Rel-/- T cells, lipopolysaccharide-stimulated Rel-/- macrophages produce higher than normal levels of GM-CSF.</clue>
</event>
<event id="E82">
<type class="Physiological_process"/>
<theme idref="T51"/>
<cause idref="A38"/>
<clue>In contrast to mitogen-activated Rel-/- T cells, lipopolysaccharide-<clueType>stimulated</clueType> Rel-/- macrophages produce higher than normal levels of GM-CSF.</clue>
</event>
<sentence id="S10">These findings establish that <term id="T54" lex="Rel" sem="Protein_family_or_group">Rel</term> can function as an activator or repressor of <term id="A8" sem="Other">gene expression</term> and is required by <term id="T55" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> for production of <term id="T56" lex="IL-3" sem="Protein_molecule">IL-3</term> and <term id="T57" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term>.</sentence>
<event CL="L2" KT="Analysis" id="E45">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="T54"/>
<clue>These findings <clueKT>establish</clueKT> that Rel <clueCL>can</clueCL> function as an <clueType>activator</clueType> or repressor <linkTheme>of</linkTheme> gene expression and is required by T lymphocytes for production of IL-3 and GM-CSF.</clue>
</event>
<event CL="L2" KT="Analysis" id="E46">
<type class="Negative_regulation"/>
<theme idref="A8"/>
<cause idref="T54"/>
<clue>These findings <clueKT>establish</clueKT> that Rel <clueCL>can</clueCL> function as an activator or <clueType>repressor</clueType> <linkTheme>of</linkTheme> gene expression and is required by T lymphocytes for production of IL-3 and GM-CSF.</clue>
</event>
<event KT="Other" id="E47">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>These findings establish that Rel can function as an activator or repressor of gene expression and is required by T lymphocytes for <clueType>production</clueType> <linkTheme>of</linkTheme> IL-3 and GM-CSF.</clue>
</event>
<event KT="Other" id="E48">
<type class="Gene_expression"/>
<theme idref="T57"/>
<clue>These findings establish that Rel can function as an activator or repressor of gene expression and is required by T lymphocytes for <clueType>production</clueType> <linkTheme>of</linkTheme> IL-3 and GM-CSF.</clue>
</event>
<event KT="Analysis" id="E49">
<type class="Positive_regulation"/>
<theme idref="E47"/>
<cause idref="T54"/>
<clue>These findings <clueKT>establish</clueKT> that Rel can function as an activator or repressor of gene expression and is <clueType>required</clueType> <clueLoc>by T lymphocytes</clueLoc> <linkTheme>for</linkTheme> production of IL-3 and GM-CSF.</clue>
</event>
<event KT="Analysis" id="E50">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<cause idref="T54"/>
<clue>These findings <clueKT>establish</clueKT> that Rel can function as an activator or repressor of gene expression and is <clueType>required</clueType> <clueLoc>by T lymphocytes</clueLoc> <linkTheme>for</linkTheme> production of IL-3 and GM-CSF.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
